{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,11]],"date-time":"2026-05-11T05:24:46Z","timestamp":1778477086289,"version":"3.51.4"},"reference-count":38,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2015,1,1]],"date-time":"2015-01-01T00:00:00Z","timestamp":1420070400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinica Chimica Acta"],"published-print":{"date-parts":[[2015,1]]},"DOI":"10.1016\/j.cca.2014.08.020","type":"journal-article","created":{"date-parts":[[2014,8,27]],"date-time":"2014-08-27T14:10:54Z","timestamp":1409148654000},"page":"171-177","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":51,"special_numbering":"C","title":["Human epididymis protein 4: Factors of variation"],"prefix":"10.1016","volume":"438","author":[{"given":"Simona","family":"Ferraro","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Domitilla","family":"Schiumarini","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mauro","family":"Panteghini","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.cca.2014.08.020_bb0005","doi-asserted-by":"crossref","first-page":"2480","DOI":"10.1158\/1055-9965.EPI-08-0150","article-title":"Effect of personal characteristics on serum CA125, mesothelin, and HE4 levels in healthy post-menopausal women at high-risk for ovarian cancer","volume":"17","author":"Lowe","year":"2008","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"10.1016\/j.cca.2014.08.020_bb0010","doi-asserted-by":"crossref","first-page":"1630","DOI":"10.1093\/jnci\/djr359","article-title":"Potential role of HE4 in multimodal screening for epithelial ovarian cancer","volume":"103","author":"Urban","year":"2011","journal-title":"J Natl Cancer Inst"},{"key":"10.1016\/j.cca.2014.08.020_bb0015","doi-asserted-by":"crossref","first-page":"440","DOI":"10.1016\/j.ygyno.2010.02.005","article-title":"Serum biomarker panels for the discrimination of benign from malignant cases in patients with an adnexal mass","volume":"117","author":"Nolen","year":"2010","journal-title":"Gynecol Oncol"},{"key":"10.1016\/j.cca.2014.08.020_bb0020","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1177\/0004563213500657","article-title":"Is serum human epididymis protein 4 ready for prime time?","volume":"51","author":"Ferraro","year":"2014","journal-title":"Ann Clin Biochem"},{"key":"10.1016\/j.cca.2014.08.020_bb0025","doi-asserted-by":"crossref","first-page":"22655","DOI":"10.3390\/ijms141122655","article-title":"HE4 transcription and splice variant specific expression in endometrial cancer and correlation with patient survival","volume":"14","author":"Jiang","year":"2013","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.cca.2014.08.020_bb0030","doi-asserted-by":"crossref","first-page":"847","DOI":"10.1038\/modpathol.3800612","article-title":"Comprehensive analysis of HE4 expression in normal and malignant human tissue","volume":"19","author":"Galgano","year":"2006","journal-title":"Mod Pathol"},{"key":"10.1016\/j.cca.2014.08.020_bb0035","doi-asserted-by":"crossref","first-page":"2496","DOI":"10.1158\/1055-9965.EPI-11-0635","article-title":"Serum human epididymis protein 4 and risk for ovarian malignancy algorithm as new diagnostic and prognostic tools for epithelial ovarian cancer management","volume":"20","author":"Bandiera","year":"2011","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"10.1016\/j.cca.2014.08.020_bb0040","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1016\/j.ygyno.2008.08.031","article-title":"A novel multiple bioassay utilizing HE4 and CA125 for the prediction of ovarian cancer in patients with a pelvic mass","volume":"112","author":"Moore","year":"2009","journal-title":"Gynecol Oncol"},{"key":"10.1016\/j.cca.2014.08.020_bb0045","first-page":"489","article-title":"Factor influencing serum CA125II levels in healthy postmenopapausal women","volume":"10","author":"Pauler","year":"2001","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"10.1016\/j.cca.2014.08.020_bb0050","first-page":"159","article-title":"Generating longitudinal screening algorithms using novel biomarkers for disease","volume":"11","author":"McIntosh","year":"2002","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"10.1016\/j.cca.2014.08.020_bb0055","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1136\/jclinpath-2012-201031","article-title":"Serum human epididymis protein 4 vs carbohydrate antigen 125 for ovarian cancer diagnosis: a systematic review","volume":"66","author":"Ferraro","year":"2013","journal-title":"J Clin Pathol"},{"key":"10.1016\/j.cca.2014.08.020_bb0060","doi-asserted-by":"crossref","first-page":"2087","DOI":"10.1158\/1055-9965.EPI-12-0616","article-title":"Interpretation of single and serial measures of HE4 and CA-125 in asymptomatic women at high risk for ovarian cancer","volume":"21","author":"Urban","year":"2012","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"10.1016\/j.cca.2014.08.020_bb0065","doi-asserted-by":"crossref","first-page":"1136","DOI":"10.1002\/ijc.26129","article-title":"Reference ranges for HE4 and CA125 in a large Asian population by automated assays and diagnostics performances for ovarian cancer","volume":"130","author":"Park","year":"2012","journal-title":"Int J Cancer"},{"key":"10.1016\/j.cca.2014.08.020_bb0070","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1007\/s13277-010-0049-1","article-title":"Ovarian tumor marker HE4 is differently expressed during the phase of menstrual cycle in healthy young women","volume":"31","author":"Anastasi","year":"2010","journal-title":"Tumour Biol"},{"key":"10.1016\/j.cca.2014.08.020_bb0075","doi-asserted-by":"crossref","first-page":"349.e1","DOI":"10.1016\/j.ajog.2011.12.028","article-title":"Serum levels of the ovarian cancer biomarker HE4 are decreased in pregnancy and increase with age","volume":"206","author":"Moore","year":"2012","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.cca.2014.08.020_bb0080","doi-asserted-by":"crossref","first-page":"667","DOI":"10.1016\/j.ygyno.2012.03.011","article-title":"Serum HE4 concentration is not dependent on menstrual cycle or hormonal treatment among endometriosis patients and healthy premenopausal women","volume":"125","author":"Hallamaa","year":"2012","journal-title":"Gynecol Oncol"},{"key":"10.1016\/j.cca.2014.08.020_bb0085","doi-asserted-by":"crossref","first-page":"1534","DOI":"10.1373\/clinchem.2010.157073","article-title":"Comparison of serum human epididymis protein 4 with cancer antigen 125 as a tumor marker in patients with malignant and nonmalignant diseases","volume":"57","author":"Escudero","year":"2011","journal-title":"Clin Chem"},{"key":"10.1016\/j.cca.2014.08.020_bb0090","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1007\/s13277-011-0256-4","article-title":"Human epididymis protein 4 reference limits and natural variation in a Nordic reference population","volume":"33","author":"Bolstad","year":"2012","journal-title":"Tumour Biol"},{"key":"10.1016\/j.cca.2014.08.020_bb0095","doi-asserted-by":"crossref","DOI":"10.1515\/cclm-2014-0097","article-title":"The importance of individual biology in the clinical use of serum biomarkers for ovarian cancer","author":"Braga","year":"2014","journal-title":"Clin Chem Lab Med"},{"key":"10.1016\/j.cca.2014.08.020_bb0100","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1258\/acb.2011.011258","article-title":"Elevated human epididymis protein 4 concentrations in chronic kidney disease","volume":"49","author":"Nagy","year":"2012","journal-title":"Ann Clin Biochem"},{"key":"10.1016\/j.cca.2014.08.020_bb0105","doi-asserted-by":"crossref","first-page":"1705","DOI":"10.1016\/j.clinbiochem.2013.08.019","article-title":"The reference intervals for HE4, CA125 and ROMA in healthy female with electrochemiluminescence immunoassay","volume":"46","author":"Yang","year":"2013","journal-title":"Clin Biochem"},{"key":"10.1016\/j.cca.2014.08.020_bb0110","doi-asserted-by":"crossref","first-page":"703","DOI":"10.1080\/00365510802126836","article-title":"Reference interval for carcinoembryonic antigen (CEA), CA125, MUC1, alfa-foeto-protein (AFP), neuron-specific enolase (NSE) and CA19.9 form the NORIP study","volume":"68","author":"Bjerner","year":"2008","journal-title":"Scand J Clin Lab Invest"},{"key":"10.1016\/j.cca.2014.08.020_bb0115","doi-asserted-by":"crossref","first-page":"360","DOI":"10.1007\/BF02940317","article-title":"Factor influencing serum concentrations of CA125 and CA15-3 in Iranian healthy post-menopausal women","volume":"13","author":"Dehaghani","year":"2007","journal-title":"Pathol Oncol Res"},{"key":"10.1016\/j.cca.2014.08.020_bb0120","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1016\/S0015-0282(16)53753-4","article-title":"Correlation between peripheral CA-125 levels and ovarian activity","volume":"54","author":"Zweers","year":"1990","journal-title":"Fertil Steril"},{"key":"10.1016\/j.cca.2014.08.020_bb0125","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1155\/1999\/960934","article-title":"Menstrual cycle dependent variability for serum tumor marker CEA, AFP, CA19.9, CA-125 and CA15-3 in healthy women","volume":"15","author":"Erbagci","year":"1999","journal-title":"Dis Markers"},{"key":"10.1016\/j.cca.2014.08.020_bb0130","doi-asserted-by":"crossref","first-page":"566","DOI":"10.1093\/humrep\/14.2.566","article-title":"Fluctuation in CA-125 and CA15-3 serum concentrations during spontaneous ovulatory cycles","volume":"14","author":"Bon","year":"1999","journal-title":"Hum Reprod"},{"key":"10.1016\/j.cca.2014.08.020_bb0135","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1016\/j.ejogrb.2004.02.039","article-title":"Use of CA-125 fluctuation during the menstrual cycle as a tool in the clinical diagnosis of endometriosis; a preliminary report","volume":"116","author":"Kafali","year":"2004","journal-title":"Eur J Obstet Gynecol Reprod Biol"},{"key":"10.1016\/j.cca.2014.08.020_bb0140","doi-asserted-by":"crossref","first-page":"409","DOI":"10.3109\/10408368909106595","article-title":"Generation and application of data on biological variation in clinical chemistry","volume":"27","author":"Fraser","year":"1989","journal-title":"Crit Rev Clin Lab Sci"},{"key":"10.1016\/j.cca.2014.08.020_bb0145","first-page":"89s","article-title":"Objective interpretation of results for tumour marker","volume":"34","author":"Browning","year":"1990","journal-title":"J Nucl Med Allied Sci"},{"key":"10.1016\/j.cca.2014.08.020_bb0150","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1006\/gyno.1999.5414","article-title":"Assessment of biological variation and analytical imprecision of CA-125, CEA, and TPA in relation to monitoring of ovarian cancer","volume":"74","author":"Tuxen","year":"1999","journal-title":"Gynecol Oncol"},{"key":"10.1016\/j.cca.2014.08.020_bb0155","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1373\/clinchem.2004.040659","article-title":"Biological variation of tumor markers and its application in the detection of disease progression in patients with non-small cell lung cancer","volume":"51","author":"Trape","year":"2005","journal-title":"Clin Chem"},{"key":"10.1016\/j.cca.2014.08.020_bb0160","doi-asserted-by":"crossref","first-page":"2127","DOI":"10.1515\/cclm-2012-0373","article-title":"HE4 in gynecological cancers: report of a European investigators and experts meeting","volume":"50","author":"Plebani","year":"2012","journal-title":"Clin Chem Lab Med"},{"key":"10.1016\/j.cca.2014.08.020_bb0165","series-title":"Ovarian cancer: the recognition and initial management of ovarian cancer","article-title":"National Institute for Health and Clinical Excellence (NICE): Guidance","author":"National Collaborating Centre for Cancer (UK)","year":"2011"},{"key":"10.1016\/j.cca.2014.08.020_bb0170","author":"Finlayson"},{"key":"10.1016\/j.cca.2014.08.020_bb0175","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1097\/IGC.0b013e318234f852","article-title":"The utility of human epididymal protein 4, cancer antigen 125, and risk for malignancy algorithm in ovarian cancer and endometriosis","volume":"22","author":"Kadija","year":"2012","journal-title":"Int J Gynecol Cancer"},{"key":"10.1016\/j.cca.2014.08.020_bb0180","doi-asserted-by":"crossref","first-page":"e45","DOI":"10.1515\/cclm-2013-0660","article-title":"Could kidney glomerular filtration impairment represent the \u201cAchilles heel\u201d of HE4 serum marker? A possible further implication","volume":"52","author":"Gizzo","year":"2014","journal-title":"Clin Chem Lab Med"},{"key":"10.1016\/j.cca.2014.08.020_bb0185","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1038\/nm.2989","article-title":"Identification of human epididymis protein 4 as a fibroblast-derived mediator of fibrosis","volume":"19","author":"LeBleu","year":"2013","journal-title":"Nat Med"},{"key":"10.1016\/j.cca.2014.08.020_bb0190","first-page":"368","article-title":"Biochemical and functional characteristics of human epididymis protein 4 (HE4)","volume":"38","author":"Schiumarini","year":"2014","journal-title":"Biochim Clin"}],"container-title":["Clinica Chimica Acta"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0009898114003726?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0009898114003726?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,8,14]],"date-time":"2019-08-14T06:58:56Z","timestamp":1565765936000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0009898114003726"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,1]]},"references-count":38,"alternative-id":["S0009898114003726"],"URL":"https:\/\/doi.org\/10.1016\/j.cca.2014.08.020","relation":{},"ISSN":["0009-8981"],"issn-type":[{"value":"0009-8981","type":"print"}],"subject":[],"published":{"date-parts":[[2015,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Human epididymis protein 4: Factors of variation","name":"articletitle","label":"Article Title"},{"value":"Clinica Chimica Acta","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.cca.2014.08.020","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2014 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}